Evidence map›Paper›PMID 24493796›Full record

ArticleThe Journal of experimental medicine2014

The TCR ligand-inducible expression of CD73 marks γδ lineage commitment and a metastable intermediate in effector specification.

Francis Coffey, Sang-Yun Lee, Terkild B Buus, Jens-Peter Holst Lauritsen, Gladys W Wong, Michelle L Joachims, Linda F Thompson, Juan Carlos Zúñiga-Pflücker, Dietmar J Kappes, David L Wiest

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  6. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Development of γδ T Cells: Soldiers on the Front Lines of Immune Battles.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  19. Article
  20. RNA mProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Francis CoffeyBlood Cell Development and Cancer Keystone, Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA 19111.
Sang-Yun Lee
Terkild B Buus
Jens-Peter Holst Lauritsen
Gladys W Wong
Michelle L Joachims
Linda F Thompson
Juan Carlos Zúñiga-Pflücker
Dietmar J Kappes
David L Wiest
Fox Chase Cancer Center · USOklahoma Medical Research Foundation · USUniversity of Copenhagen · DKSunnybrook Health Science Centre · CAUniversity of Toronto · CA

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
The Regulation of Inflammatory Responses by CD73R01AI018220 · NIAID · SCRIPPS CLINIC AND RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 1985 to 2012
$3.1M
Control of alpha-beta/gamma-delta T Lineage CommitmentR01AI081314 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2009 to 2013
$2.1M
Role of RPL22 in Thymocyte DevelopmentR01AI073920 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2007 to 2011
$2.1M
Role of RPL22 in Thymocyte DevelopmentR56AI073920 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2012 to 2012
$446k
Control of Gamma-Delta T Cell Lineage CommitmentF32AI098241 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI COFFEY, FRANCIS J. · 2012 to 2013
$106k
CIHR MOP-42387NCI NIH HHS P01CA06927NCI NIH HHS P30 CA006927NCI NIH HHS T32 CA009035NCI NIH HHS T32CA903536NIAID NIH HHS AI018220NIAID NIH HHS AI073920NIAID NIH HHS AI081314NIAID NIH HHS F32 AI098241NIAID NIH HHS F32AI098241NIAID NIH HHS R01 AI018220NIAID NIH HHS R01 AI073920NIAID NIH HHS R01 AI081314NIAID NIH HHS R56 AI073920NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK-50306
6 · The paper itself

Abstract

Numerous studies indicate that γδ T cell receptor (γδTCR) expression alone does not reliably mark commitment of early thymic progenitors to the γδ fate. This raises the possibility that the γδTCR is unable to intrinsically specify fate and instead requires additional environmental factors, including TCR-ligand engagement. We use single cell progenitor assays to reveal that ligand acts instructionally to direct adoption of the γδ fate. Moreover, we identify CD73 as a TCR ligand-induced cell surface protein that distinguishes γδTCR-expressing CD4(-)CD8(-) progenitors that have committed to the γδ fate from those that have not yet done so. Indeed, unlike CD73(-) γδTCR(+) progenitors, which largely adopt the αβ fate upon separation from the intrathymic selecting environment, those that express CD73 remain CD4(-)CD8(-) and committed to the γδ fate. CD73 is expressed by >90% of peripheral γδ cells, suggesting this is a common occurrence during development. Moreover, CD73 induction appears to mark a metastable intermediate stage before acquisition of effector function, suggesting that γδ lineage and effector fate are specified sequentially. These findings have important implications for the role of ligand in γδ lineage commitment and its relationship to the specification of effector fate.

Indexed as

5'-NucleotidaseAnimalsCell LineageLigandsLymphopoiesisMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsMice, TransgenicModels, ImmunologicalPrecursor Cells, T-LymphoidReceptors, Antigen, T-Cell, gamma-deltaT-Lymphocyte Subsets5'-NucleotidaseLigandsReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID24493796
PMCPMC3920555
OpenAlexW2106211984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.